Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Moving Toward Biomarker-Driven Care in Bladder Cancer
Moving Toward Biomarker-Driven Care in Bladder Cancer
Project Oncology®
Moving Toward Biomarker-Driven Care in Bladder Cancer
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
What's Next for Urothelial Cancer Treatment?
What's Next for Urothelial Cancer Treatment?
Project Oncology®
What's Next for Urothelial Cancer Treatment?
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
A Long-Term View of Cardiovascular Risk After Cancer Treatment
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Heart Matters
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
- Stephanie Dixon, MD, MPH
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Project Oncology®
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Caner Saygin, MD
- Caner Saygin, MD
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Heart Matters
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Stephanie Dixon, MD, MPH
- Stephanie Dixon, MD, MPH
How Myeloid Mutations in ALL Inform Treatment Decisions
How Myeloid Mutations in ALL Inform Treatment Decisions
Project Oncology®
How Myeloid Mutations in ALL Inform Treatment Decisions
Caner Saygin, MD
- Caner Saygin, MD
A Look at WCLC 2026: Pivotal Trials and Emerging Directions
A Look at WCLC 2026: Pivotal Trials and Emerging Directions
Project Oncology®
A Look at WCLC 2026: Pivotal Trials and Emerging Directions
Triparna Sen, PhD
- Triparna Sen, PhD
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Project Oncology®
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Triparna Sen, PhD
- Triparna Sen, PhD

Medical News

Medical News
Levofloxacin Prophylaxis Failure Tied to Resistance and PK/PD
09/10/2026
Read more
Medical News
More Negative Sentinel Nodes Didn’t Improve Breast Cancer Outcomes
09/04/2026
Read more
Medical News
Real-World ALK TKI Outcomes in Metastatic NSCLC
09/04/2026
Read more
Medical News
Predicting Pneumonia After Brain Tumor Surgery
09/04/2026
Read more

CME/CE

The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP; Virginia Kaklamani, MD, DSc
0.50 program credits
- Komal Jhaveri, MD, FACP
- Virginia Kaklamani, MD, DSc
0.50 program credits
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
MinuteCE®
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Virginia Kaklamani, MD, DSc
0.50 program credits
- Virginia Kaklamani, MD, DSc
0.50 program credits
MinuteCE®
Oral SERDs and PROTACs in ER+/HER2− mBC: Testing Smarter, Treating Better
Komal Jhaveri, MD, FACP; Virginia Kaklamani, MD, DSc
0.50 credits 4 episodes
- Komal Jhaveri, MD, FACP
- Virginia Kaklamani, MD, DSc
0.50 credits 4 episodes
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
CME/CE Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 24, 2026
06:00 PM - 07:00 PM ET
1.00 credit

Clinical Practice

Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Project Oncology®
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Benjamin Garmezy, MD
- Benjamin Garmezy, MD
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Project Oncology®
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Jonathon B. Cohen, MD, MS
- Jonathon B. Cohen, MD, MS
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Project Oncology®
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Kerry A. Rogers, MD
- Kerry A. Rogers, MD
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Clinician's Roundtable
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Peter Buch, MD, FACG, AGAF, FACP; Mallik Greene, PhD
- Peter Buch, MD, FACG, AGAF, FACP
- Mallik Greene, PhD
- Jordan Karlitz, MD

Programs

Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Clinician's Roundtable
Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Shelina Ramnarine, PhD; David A. Johnson, MD, FACG, FACP
- Shelina Ramnarine, PhD
- David A. Johnson, MD, FACG, FACP
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Komal Jhaveri, MD, FACP
0.50 program credits
- Komal Jhaveri, MD, FACP
0.50 program credits
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Komal Jhaveri, MD, FACP; Virginia Kaklamani, MD, DSc
0.50 program credits
- Komal Jhaveri, MD, FACP
- Virginia Kaklamani, MD, DSc
0.50 program credits
Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Project Oncology®
Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Lajos Pusztai, MD, DPhil
- Lajos Pusztai, MD, DPhil